Slovenian recommendations for the management of chronic myeloid leukaemia

Lignende værker

• CML treatment results in Slovenia in the era of tirozin kinaze inhibitors
  af: Irena Preložnik Zupan, et al.
  Udgivet: (2012-12-01)
• Imatinib plasma concentration – a new laboratory parameter for monitoring the treatment of Slovenian patients with chronic myeloid leukemia
  af: Jernej Mlakar, et al.
  Udgivet: (2011-03-01)
• Severe adverse effects associated with tyrosine kinase inhibitors therapy in chronic myeloid leukaemia – case reports and literature review
  af: Frosina Krstanovska, et al.
  Udgivet: (2011-05-01)
• Slovenian recommendations for the management of chronic myeloid leukaemia
  af: Irena Preložnik Zupan, et al.
  Udgivet: (2018-04-01)
• Bcr-aBL1 kinase domain mutation analysis in chronic myeloid leukaemia patients with suboptimal response to tyrosine kinase inhibitors
  af: Tadej Pajič, et al.
  Udgivet: (2012-12-01)